This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bovine High-Mountain Disease Market

Market Insights on Bovine High-Mountain Disease covering sales outlook, demand forecast & up-to-date key trends

Bovine High-Mountain Disease Market By Drug Class (Diuretics, Antibiotics, Appetite Stimulators), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Veterinary Pharmaceutical Store) & Region - Forecast 2022-2032

Bovine High-Mountain Disease Market Overview

Global Bovine high-mountain disease demand is projected to be valued at US$ 4.32 Billion in 2022, forecast to grow at a CAGR of 5.25% to be valued at US$ 7.2 Billion from 2022 to 2032. Growth is attributed to the rising demand for renovation projects and development in residential and commercial construction.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 4.1 Billion

Expected Market Value (2022)

US$ 4.32 Billion

Anticipated Forecast Value (2032)

US$ 7.2 Billion

Projected Growth Rate (2022-2032)

5.25% CAGR

Bovine high-mountain disease (BHMD) is also known as brisket disease which causes significant death loss, especially in calves. The bovine high-mountain disease is right heart failure which is generally caused due to hypoxic pulmonary hypertension at high altitudes. The bovine high-mountain disease is found in cattle at elevations over 7,000 feet and affects cattle of all ages and breeds.

Higher elevations directly increase the incidence rate of bovine respiratory disease. The bovine high-mountain disease is generally associated with factors like altitude, physiologic, genetic, and environmental. It is also said that bovine high-mountain disease could be associated with mortality and morbidity associated with bovine respiratory disease (BRD). Some of the symptoms associated with the bovine high-mountain disease are weakness, collapse, diarrhea, bulging eyes, swelling due to edema of the limbs, and others.

Which are Some Prominent Drivers Spearheading Bovine high-mountain diseases Market Growth?

The rising incidence of congestive heart failure in cattle is considered a major driving factor in driving the growth of the global bovine high-mountain disease market. Furthermore, the rising prevalence of respiratory disease, lung abscesses, migrating parasitic larvae and lungworms, and genetic susceptibility further contribute to boosting the growth of the global bovine high-mountain disease drug market.

A susceptible animal is generally more prone to develop bovine high-mountain disease if any of the above parameters are present.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Bovine High-Mountain Disease Industry?

There are also other diseases (like congenital heart disease, parasites, etc.) that are very similar to the bovine high-mountain disease which often causes difficulties in differentiating them. Thus, the lack of information about the bovine high-mountain disease is expected to hamper the growth of the global bovine high-mountain disease market.

Generally, a pulmonary artery pressure (PAP) test is conducted in order to determine the bovine high-mountain disease. The high cost related to the treatment of bovine high-mountain disease is also expected to deter the growth of the global bovine high-mountain disease market.

Why is Asia-Pacific Emerging as an Opportunistic Bovine high-mountain disease Market?

APAC region has witnessed a tremendous increment in the bovine high-mountain disease in the past 2 to 3 decades. Numerous range plants, both browse and non-browse types, have been linked with augmented incidence of BHMD, but only locoweed has been experimentally shown to induce the disease.

Moreover, owing to poor health facilities in the hilly areas, the cattle are unable to get proper treatment and oxygen support due to high altitude. Governments of several countries are setting up veterinary hospitals in hilly residential areas to provide quick medical support, thereby, fostering the bovine high-mountain disease drug market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to the Growth of the Bovine high-mountain disease Market?

Western Europe is anticipated to register the second most market share in the global bovine high-mountain disease market due to the presence of established manufacturers in the region. The Latin American bovine high-mountain disease market is expected to grow at a significant growth rate over the forecast period.

Why does North America Hold a Significant Share in the Bovine high-mountain disease Market?

North American bovine high-mountain disease market is anticipated to register a maximum market share in the global bovine high-mountain disease market. The bovine high-mountain disease is very common in cattle raised on ranches at high altitudes (more than 5,000 feet) in Colorado, Wyoming, New Mexico, and Utah. It also affects cattle in mountainous ranges of the world, most commonly at elevations >6,500 ft (1,981 m) in western Canada and South America. BHMD affects cattle of all ages and breeds, but not necessarily equally.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the key participants present in the global demand of the Bovine high-mountain disease market include Zoetis, Inc., Bayer AG, Eli Lilly and Company (Elanco), Dechra Pharmaceuticals, Merck & Co., Inc, and others.

  • In March 2021, Zoetis Inc. announced its long-term sustainability goals, which were built on the company’s purpose to nurture the world and humankind by advancing care for animals. Under the banner Driven to Care, Zoetis brings to life its specific commitments to Communities, Animals, and the Planet, including support of 10 of the 17 United Nations’ Sustainable Development Goals (SDGs). 

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.25% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Type
  • Function
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Poland
  • Russia
  • Australia & New Zealand
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Zoetis, Inc.
  • Bayer AG,
  • Eli Lilly and Company (Elanco)
  • Dechra Pharmaceuticals
  • Merck & Co., Inc.

Customization

Available Upon Request

Key Segments Profiled in the Bovine High-Mountain Disease Industry Survey

By Drug Class:

  • Bovine High-Mountain Disease Diuretics
  • Bovine High-Mountain Disease Antibiotics
  • Bovine High-Mountain Disease Appetite Stimulators
  • Other Bovine High-Mountain Disease Drugs

By Distribution Channel:

  • Bovine High-Mountain Disease Drugs Sales via Veterinary Hospitals
  • Bovine High-Mountain Disease Drugs Sales via Veterinary Clinics
  • Bovine High-Mountain Disease Drugs Sales via Veterinary Pharmaceutical Stores
  • Bovine High-Mountain Disease Drugs Sales via Other Distribution Channels

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Frequently Asked Questions

FMI projects the global demand of the bovine high-mountain disease market to expand at a 5.25% value CAGR by 2032

Which region is forecast to be the most lucrative for bovine high-mountain disease market growth?

Zoetis, Inc., Bayer AG, Eli Lilly and Company (Elanco), Dechra Pharmaceuticals, Merck & Co., Inc, and others.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Bovine High-Mountain Disease Market